BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Budach V, Tinhofer I. Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review. The Lancet Oncology 2019;20:e313-26. [DOI: 10.1016/s1470-2045(19)30177-9] [Cited by in Crossref: 54] [Cited by in F6Publishing: 28] [Article Influence: 18.0] [Reference Citation Analysis]
Number Citing Articles
1 Verrelle P, Meseure D, Berger F, Forest A, Leclère R, Nicolas A, Fortas E, Sastre-Garau X, Lae M, Boudjemaa S, Mbagui R, Calugaru V, Labiod D, De Koning L, Almouzni G, Quivy JP. CENP-A Subnuclear Localization Pattern as Marker Predicting Curability by Chemoradiation Therapy for Locally Advanced Head and Neck Cancer Patients. Cancers (Basel) 2021;13:3928. [PMID: 34439087 DOI: 10.3390/cancers13163928] [Reference Citation Analysis]
2 Chen L, Ling Y, Yang H, Mei J. Comprehensive Analysis of the Potential Prognostic Value of 11 Glycosylation-Related Genes in Head and Neck Squamous Cell Carcinoma and Their Correlation with PD-L1 Expression and Immune Infiltration. Journal of Oncology 2022;2022:1-16. [DOI: 10.1155/2022/2786680] [Reference Citation Analysis]
3 Wojakowska A, Zebrowska A, Skowronek A, Rutkowski T, Polanski K, Widlak P, Marczak L, Pietrowska M. Metabolic Profiles of Whole Serum and Serum-Derived Exosomes Are Different in Head and Neck Cancer Patients Treated by Radiotherapy. J Pers Med 2020;10:E229. [PMID: 33203021 DOI: 10.3390/jpm10040229] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
4 Lu T, Zheng Y, Gong X, Lv Q, Chen J, Tu Z, Lin S, Pan J, Guo Q, Li J. High Expression of Hyaluronan-Mediated Motility Receptor Predicts Adverse Outcomes: A Potential Therapeutic Target for Head and Neck Squamous Cell Carcinoma. Front Oncol 2021;11:608842. [PMID: 33763352 DOI: 10.3389/fonc.2021.608842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Jiang M, Liu F, Yang AG, Wang W, Zhang R. The role of long non-coding RNAs in the pathogenesis of head and neck squamous cell carcinoma. Mol Ther Oncolytics 2022;24:127-38. [PMID: 35024439 DOI: 10.1016/j.omto.2021.12.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Gu X, Wang L, Coates PJ, Boldrup L, Fåhraeus R, Wilms T, Sgaramella N, Nylander K. Transfer-RNA-Derived Fragments Are Potential Prognostic Factors in Patients with Squamous Cell Carcinoma of the Head and Neck. Genes (Basel) 2020;11:E1344. [PMID: 33202812 DOI: 10.3390/genes11111344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Jakob M, Sharaf K, Schirmer M, Leu M, Küffer S, Bertlich M, Ihler F, Haubner F, Canis M, Kitz J. Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC. Strahlenther Onkol 2021;197:231-45. [PMID: 32588101 DOI: 10.1007/s00066-020-01653-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
8 von der Grün J, Winkelmann R, Burck I, Martin D, Rödel F, Wild PJ, Bankov K, Weigert A, Kur I, Brandts C, Filmann N, Issing C, Thönissen P, Tanneberger AM, Rödel C, Ghanaati S, Balermpas P. Neoadjuvant Chemoradiotherapy for Oral Cavity Cancer: Predictive Factors for Response and Interim Analysis of the Prospective INVERT-Trial. Front Oncol 2022;12:817692. [DOI: 10.3389/fonc.2022.817692] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Murakami N, Mori T, Kubo Y, Yoshimoto S, Ito K, Honma Y, Ueno T, Kobayashi K, Okamoto H, Boku N, Takahashi K, Inaba K, Okuma K, Igaki H, Nakayama Y, Itami J. Prognostic impact of immunohistopathologic features in definitive radiation therapy for nasopharyngeal cancer patients. J Radiat Res 2020;61:161-8. [PMID: 31822892 DOI: 10.1093/jrr/rrz071] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Li M, Ding X, Zhang Y, Li X, Zhou H, Yang L, Li Y, Yang P, Zhang X, Hu J, Nice E, Wu H, Xu H. Antisense oligonucleotides targeting lncRNA AC104041.1 induces antitumor activity through Wnt2B/β-catenin pathway in head and neck squamous cell carcinomas. Cell Death Dis 2020;11:672. [PMID: 32826863 DOI: 10.1038/s41419-020-02820-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
11 Altay-Langguth A, Balermpas P, Brandts C, Balster S, Ghanaati S, Winkelmann R, Burck I, Rödel F, Martin D, Rödel C, von der Grün J. Re-irradiation with concurrent and maintenance nivolumab in locally recurrent and inoperable squamous cell carcinoma of the head and neck: A single-center cohort study. Clin Transl Radiat Oncol 2021;28:71-8. [PMID: 33889760 DOI: 10.1016/j.ctro.2021.03.004] [Reference Citation Analysis]
12 Catalán M, Rodríguez C, Olmedo I, Carrasco-Rojas J, Rojas D, Molina-Berríos A, Díaz-Dosque M, Jara JA. Kaempferol Induces Cell Death and Sensitizes Human Head and Neck Squamous Cell Carcinoma Cell Lines to Cisplatin. Adv Exp Med Biol 2021;1326:95-109. [PMID: 33368015 DOI: 10.1007/5584_2020_603] [Reference Citation Analysis]
13 Li J, Chen W, Luo L, Liao L, Deng X, Wang Y. The microRNA miR-29c-5p inhibits cell proliferation and migration by targeting TMEM98 in head and neck carcinoma. Aging (Albany NY) 2020;13:769-81. [PMID: 33257597 DOI: 10.18632/aging.202183] [Reference Citation Analysis]
14 Pace L, Nicolai E, Cavaliere C, Basso L, Garbino N, Spinato G, Salvatore M. Prognostic value of 18F-FDG PET/MRI in patients with advanced oropharyngeal and hypopharyngeal squamous cell carcinoma. Ann Nucl Med 2021;35:479-84. [PMID: 33575927 DOI: 10.1007/s12149-021-01590-y] [Reference Citation Analysis]
15 Philouze P, Gauthier A, Lauret A, Malesys C, Muggiolu G, Sauvaigo S, Galmiche A, Ceruse P, Alphonse G, Wozny AS, Rodriguez-Lafrasse C. CD44, γ-H2AX, and p-ATM Expressions in Short-Term Ex Vivo Culture of Tumour Slices Predict the Treatment Response in Patients with Oral Squamous Cell Carcinoma. Int J Mol Sci 2022;23:877. [PMID: 35055060 DOI: 10.3390/ijms23020877] [Reference Citation Analysis]
16 Sharon S, Duhen T, Bambina S, Baird J, Leidner R, Bell B, Casap N, Crittenden M, Vasudevan S, Jubran M, Kravchenko-Balasha N, Gough M. Explant Modeling of the Immune Environment of Head and Neck Cancer. Front Oncol 2021;11:611365. [PMID: 34221953 DOI: 10.3389/fonc.2021.611365] [Reference Citation Analysis]
17 Defelice BC, Fiehn O, Belafsky P, Ditterich C, Moore M, Abouyared M, Beliveau AM, Farwell DG, Bewley AF, Clayton SM, Archard JA, Pavlic J, Rao S, Kuhn M, Deng P, Halmai J, Fink KD, Birkeland AC, Anderson JD. Polyamine Metabolites as Biomarkers in Head and Neck Cancer Biofluids. Diagnostics 2022;12:797. [DOI: 10.3390/diagnostics12040797] [Reference Citation Analysis]
18 Zhou Z, Mu D, Zhang D, Zhang X, Ding X, Yang J, Bai X, Hu M. PD-L1 in Combination with CD8+TIL and HIF-1α are Promising Prognosis Predictors of Head and Neck Squamous Cell Carcinoma. Cancer Manag Res 2020;12:13233-9. [PMID: 33380831 DOI: 10.2147/CMAR.S285691] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Chen J, Lu T, Zhong F, Lv Q, Fang M, Tu Z, Ji Y, Li J, Gong X. A Signature of N6-methyladenosine Regulator-Related Genes Predicts Prognoses and Immune Responses for Head and Neck Squamous Cell Carcinoma. Front Immunol 2022;13:809872. [PMID: 35185897 DOI: 10.3389/fimmu.2022.809872] [Reference Citation Analysis]
20 Li X, Zhao S, Fu Y, Zhang P, Zhang Z, Cheng J, Liu L, Jiang H. miR-34a-5p functions as a tumor suppressor in head and neck squamous cell cancer progression by targeting Flotillin-2. Int J Biol Sci 2021;17:4327-39. [PMID: 34803501 DOI: 10.7150/ijbs.64851] [Reference Citation Analysis]
21 van der Heijden M, Essers PBM, de Jong MC, de Roest RH, Sanduleanu S, Verhagen CVM, Hamming-Vrieze O, Hoebers F, Lambin P, Bartelink H, Leemans CR, Verheij M, Brakenhoff RH, van den Brekel MWM, Vens C. Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation. Front Oncol 2019;9:1470. [PMID: 31998639 DOI: 10.3389/fonc.2019.01470] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
22 Xue F, Wang T, Shi H, Feng H, Feng G, Wang R, Yao Y, Yuan H. CD73 facilitates invadopodia formation and boosts malignancy of head and neck squamous cell carcinoma via the MAPK signaling pathway. Cancer Sci 2022. [PMID: 35657703 DOI: 10.1111/cas.15452] [Reference Citation Analysis]
23 Rabasco Meneghetti A, Zwanenburg A, Leger S, Leger K, Troost EG, Linge A, Lohaus F, Schreiber A, Kalinauskaite G, Tinhofer I, Guberina N, Guberina M, Balermpas P, von der Grün J, Ganswindt U, Belka C, Peeken JC, Combs SE, Böke S, Zips D, Krause M, Baumann M, Löck S. Definition and validation of a radiomics signature for loco-regional tumour control in patients with locally advanced head and neck squamous cell carcinoma. Clinical and Translational Radiation Oncology 2021;26:62-70. [DOI: 10.1016/j.ctro.2020.11.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Ai D, Dou Y, Nan Z, Wang K, Wang H, Zhang L, Dong Z, Sun J, Ma C, Tan W, Gao W, Liu J, Zhao L, Liu S, Song B, Shao Q, Qu X. CD68+ Macrophage Infiltration Associates With Poor Outcome of HPV Negative Oral Squamous Carcinoma Patients Receiving Radiation: Poly(I:C) Enhances Radiosensitivity of CAL-27 Cells but Promotes Macrophage Recruitment Through HMGB1. Front Oncol 2021;11:740622. [PMID: 34568076 DOI: 10.3389/fonc.2021.740622] [Reference Citation Analysis]
25 Li Y, Hong X, Zhang Y, Li Y, Lei Y, He Q, Yang X, Liang Y, Ma J, Liu N. A gene expression-based immune content predictor for survival and postoperative radiotherapy response in head and neck cancer. Mol Ther Oncolytics 2021;22:380-7. [PMID: 34553026 DOI: 10.1016/j.omto.2021.06.013] [Reference Citation Analysis]
26 Hazawa M, Yoshino H, Nakagawa Y, Shimizume R, Nitta K, Sato Y, Sato M, Wong RW, Kashiwakura I. Karyopherin-β1 Regulates Radioresistance and Radiation-Increased Programmed Death-Ligand 1 Expression in Human Head and Neck Squamous Cell Carcinoma Cell Lines. Cancers (Basel) 2020;12:E908. [PMID: 32276424 DOI: 10.3390/cancers12040908] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Saidak Z, Lailler C, Testelin S, Chauffert B, Clatot F, Galmiche A. Contribution of Genomics to the Surgical Management and Study of Oral Cancer. Ann Surg Oncol 2021. [PMID: 33846893 DOI: 10.1245/s10434-021-09904-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Amez Martín M, Wuhrer M, Falck D. Serum and Plasma Immunoglobulin G Fc N-Glycosylation Is Stable during Storage. J Proteome Res 2021;20:2935-41. [PMID: 33909442 DOI: 10.1021/acs.jproteome.1c00148] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Liu C, Wu W, Xu M, Mi J, Xu L, Wang R. Development and Validation of an Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma. Biomed Res Int 2021;2021:1028158. [PMID: 34423028 DOI: 10.1155/2021/1028158] [Reference Citation Analysis]
30 Yahya N, Linge A, Leger K, Maile T, Kemper M, Haim D, Jöhrens K, Troost EGC, Krause M, Löck S. Assessment of gene expressions from squamous cell carcinoma of the head and neck to predict radiochemotherapy-related xerostomia and dysphagia. Acta Oncol 2022;:1-8. [PMID: 35657056 DOI: 10.1080/0284186X.2022.2081931] [Reference Citation Analysis]
31 Yang Y, Wang R, Feng L, Ma H, Fang J. LINC00460 Promotes Cell Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition of Head and Neck Squamous Cell Carcinoma via miR-320a/BGN Axis. Onco Targets Ther 2021;14:2279-91. [PMID: 33833526 DOI: 10.2147/OTT.S282947] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Tinhofer I, Braunholz D, Klinghammer K. Preclinical models of head and neck squamous cell carcinoma for a basic understanding of cancer biology and its translation into efficient therapies. Cancers Head Neck 2020;5:9. [PMID: 32714605 DOI: 10.1186/s41199-020-00056-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Seok J, Ryu CH, Ryu J, Kim JH, Lee SJ, Park WS, Jung YS. Prognostic Implication of SOX2 Expression Associated with p16 in Oropharyngeal Cancer: A Study of Consecutive Tissue Microarrays and TCGA. Biology (Basel) 2020;9:E387. [PMID: 33182283 DOI: 10.3390/biology9110387] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Ishikawa S, Sugimoto M, Konta T, Kitabatake K, Ueda S, Edamatsu K, Okuyama N, Yusa K, Iino M. Salivary Metabolomics for Prognosis of Oral Squamous Cell Carcinoma. Front Oncol 2021;11:789248. [PMID: 35070995 DOI: 10.3389/fonc.2021.789248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Ding Y, Feng G, Yang M. Prognostic role of alternative splicing events in head and neck squamous cell carcinoma. Cancer Cell Int 2020;20:168. [PMID: 32467664 DOI: 10.1186/s12935-020-01249-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Liu J, Lu J, Li W. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma. BMC Cancer 2022;22:352. [PMID: 35361159 DOI: 10.1186/s12885-022-09449-9] [Reference Citation Analysis]
37 Duan F, Zhai W, Zhang B, Guo S. Urachal carcinoma: Impact of recurrence pattern and lymphadenectomy on long-term outcomes. Cancer Med 2020;9:4166-74. [PMID: 32329250 DOI: 10.1002/cam4.3059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
38 Li J, Wu YL, Li WF, Ma J. Neutrophil to apolipoprotein A-I ratio as an independent indicator of locally advanced nasopharyngeal carcinoma. Laryngoscope Investig Otolaryngol 2021;6:1049-61. [PMID: 34667849 DOI: 10.1002/lio2.660] [Reference Citation Analysis]
39 Kwon EJ, Ha M, Jang JY, Kim YH. Identification and Complete Validation of Prognostic Gene Signatures for Human Papillomavirus-Associated Cancers: Integrated Approach Covering Different Anatomical Locations. J Virol 2021;95:e02354-20. [PMID: 33361419 DOI: 10.1128/JVI.02354-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Huang R, Wang Y, Ge H, Wang D, Wang Y, Zhang W, Yang J, Cheng J. Restoration of TET2 deficiency inhibits tumor growth in head neck squamous cell carcinoma. Ann Transl Med 2020;8:329. [PMID: 32355773 DOI: 10.21037/atm.2020.02.145] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
41 Huang GJ. Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck cancer with lung metastasis. Eur Arch Otorhinolaryngol 2022. [PMID: 35435449 DOI: 10.1007/s00405-022-07394-8] [Reference Citation Analysis]
42 Lu T, Chen Y, Gong X, Guo Q, Lin C, Luo Q, Tu Z, Pan J, Li J. SEC61G overexpression and DNA amplification correlates with prognosis and immune cell infiltration in head and neck squamous cell carcinoma. Cancer Med 2021;10:7847-62. [PMID: 34590792 DOI: 10.1002/cam4.4301] [Cited by in F6Publishing: 1] [Reference Citation Analysis]